ARCHIVES

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

House Committee Expands Rauscher Pay Bill, Includes All NIH Directors, Asst. Secretary

July 30, 1976

NIES Issue RFA For Studies On Alternative Types Of Cancer Bioassay

October 31, 1980

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985

In Brief: ACS Considers Expanding Psychosocial Program, Taylor Says; Mendelsohn, Pitot Join NTP Board

March 25, 1983

In Brief: Mammography Quality assurance Act Introduced Laurence Marton Succeeds Brown At Wisconsin

November 1, 1991